Discontinued — last reported Q4 '25
U.S. Bancorp Interest Paid remained flat by 0.0% to $3.60B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 6.5%, from $3.85B to $3.60B. Over 4 years (FY 2021 to FY 2025), Interest Paid shows an upward trend with a 91.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
cf_interest_paid| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $1.06B | $2.72B | $12.28B | $15.38B | $14.39B |
| YoY Change | — | +156.1% | +352.0% | +25.2% | -6.5% |